Global Ketorolac Market Research Report 2020-2026

  • receipt Report ID : 27028
  • calendar_today Published On: Apr, 2020
  • file_copy Pages: 114
  • list Chemicals and Materials

In 2020, the market size of Ketorolac is million US$ and it will reach million US$ in 2026, growing at a CAGR of from 2020; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.

In this report, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Ketorolac.

This report studies the global market size of Ketorolac, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).

This study presents the Ketorolac production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2015 to 2020, and forecast to 2026.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2015 to 2020.

In global market, the following companies are covered:

Allergan

DeepCare Health

Cadila

FDC

Intas Laboratories

Gufic Chem

Ranbaxy

Adley Formulation

Neon Laboratories

Sun Pharmaceutical Industries

Cipla

Dallas Pharmaceuticals

Nicholas Piramal India

AHPL

Market Segment by Product Type

Tables

Injection

Other

Market Segment by Application

Medical Uses

Chemistry Uses

Other

Key Regions split in this report: breakdown data for each region.

United States

China

European Union

Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:

To analyze and research the Ketorolac status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.

To present the key Ketorolac manufacturers, presenting the sales, revenue, market share, and recent development for key players.

To split the breakdown data by regions, type, companies and applications

To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

To identify significant trends, drivers, influence factors in global and regions

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Ketorolac are as follows:

History Year: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Year 2020 to 2026

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Report Overview

1.1 Research Scope

1.2 Major Manufacturers Covered in This Report

1.3 Market Segment by Type

1.3.1 Global Ketorolac Market Size Growth Rate by Type (2020-2026)

1.3.2 Tables

1.3.3 Injection

1.3.4 Other

1.4 Market Segment by Application

1.4.1 Global Ketorolac Market Share by Application (2020-2026)

1.4.2 Medical Uses

1.4.3 Chemistry Uses

1.4.4 Other

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Production and Capacity Analysis

2.1.1 Global Ketorolac Production Value 2015-2026

2.1.2 Global Ketorolac Production 2015-2026

2.1.3 Global Ketorolac Capacity 2015-2026

2.1.4 Global Ketorolac Marketing Pricing and Trends

2.2 Key Producers Growth Rate (CAGR) 2020-2026

2.2.1 Global Ketorolac Market Size CAGR of Key Regions

2.2.2 Global Ketorolac Market Share of Key Regions

2.3 Industry Trends

2.3.1 Market Top Trends

2.3.2 Market Drivers

3 Market Share by Manufacturers

3.1 Capacity and Production by Manufacturers

3.1.1 Global Ketorolac Capacity by Manufacturers

3.1.2 Global Ketorolac Production by Manufacturers

3.2 Revenue by Manufacturers

3.2.1 Ketorolac Revenue by Manufacturers (2015-2020)

3.2.2 Ketorolac Revenue Share by Manufacturers (2015-2020)

3.2.3 Global Ketorolac Market Concentration Ratio (CR5 and HHI)

3.3 Ketorolac Price by Manufacturers

3.4 Key Manufacturers Ketorolac Plants/Factories Distribution and Area Served

3.5 Date of Key Manufacturers Enter into Ketorolac Market

3.6 Key Manufacturers Ketorolac Product Offered

3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Production and Production Value for Each Type

4.1.1 Tables Production and Production Value (2015-2020)

4.1.2 Injection Production and Production Value (2015-2020)

4.1.3 Other Production and Production Value (2015-2020)

4.2 Global Ketorolac Production Market Share by Type

4.3 Global Ketorolac Production Value Market Share by Type

4.4 Ketorolac Ex-factory Price by Type

5 Market Size by Application

5.1 Overview

5.2 Global Ketorolac Consumption by Application

6 Production by Regions

6.1 Global Ketorolac Production (History Data) by Regions 2015-2020

6.2 Global Ketorolac Production Value (History Data) by Regions

6.3 United States

6.3.1 United States Ketorolac Production Growth Rate 2015-2020

6.3.2 United States Ketorolac Production Value Growth Rate 2015-2020

6.3.3 Key Players in United States

6.3.4 United States Ketorolac Import & Export

6.4 European Union

6.4.1 European Union Ketorolac Production Growth Rate 2015-2020

6.4.2 European Union Ketorolac Production Value Growth Rate 2015-2020

6.4.3 Key Players in European Union

6.4.4 European Union Ketorolac Import & Export

6.5 China

6.5.1 China Ketorolac Production Growth Rate 2015-2020

6.5.2 China Ketorolac Production Value Growth Rate 2015-2020

6.5.3 Key Players in China

6.5.4 China Ketorolac Import & Export

6.6 Rest of World

6.6.1 Japan

6.6.2 Korea

6.6.3 India

6.6.4 Southeast Asia

7 Ketorolac Consumption by Regions

7.1 Global Ketorolac Consumption (History Data) by Regions

7.2 United States

7.2.1 United States Ketorolac Consumption by Type

7.2.2 United States Ketorolac Consumption by Application

7.3 European Union

7.3.1 European Union Ketorolac Consumption by Type

7.3.2 European Union Ketorolac Consumption by Application

7.4 China

7.4.1 China Ketorolac Consumption by Type

7.4.2 China Ketorolac Consumption by Application

7.5 Rest of World

7.5.1 Rest of World Ketorolac Consumption by Type

7.5.2 Rest of World Ketorolac Consumption by Application

7.5.1 Japan

7.5.2 Korea

7.5.3 India

7.5.4 Southeast Asia

8 Company Profiles

8.1 Allergan

8.1.1 Allergan Company Details

8.1.2 Company Description and Business Overview

8.1.3 Production and Revenue of Ketorolac

8.1.4 Ketorolac Product Introduction

8.1.5 Allergan Recent Development

8.2 DeepCare Health

8.2.1 DeepCare Health Company Details

8.2.2 Company Description and Business Overview

8.2.3 Production and Revenue of Ketorolac

8.2.4 Ketorolac Product Introduction

8.2.5 DeepCare Health Recent Development

8.3 Cadila

8.3.1 Cadila Company Details

8.3.2 Company Description and Business Overview

8.3.3 Production and Revenue of Ketorolac

8.3.4 Ketorolac Product Introduction

8.3.5 Cadila Recent Development

8.4 FDC

8.4.1 FDC Company Details

8.4.2 Company Description and Business Overview

8.4.3 Production and Revenue of Ketorolac

8.4.4 Ketorolac Product Introduction

8.4.5 FDC Recent Development

8.5 Intas Laboratories

8.5.1 Intas Laboratories Company Details

8.5.2 Company Description and Business Overview

8.5.3 Production and Revenue of Ketorolac

8.5.4 Ketorolac Product Introduction

8.5.5 Intas Laboratories Recent Development

8.6 Gufic Chem

8.6.1 Gufic Chem Company Details

8.6.2 Company Description and Business Overview

8.6.3 Production and Revenue of Ketorolac

8.6.4 Ketorolac Product Introduction

8.6.5 Gufic Chem Recent Development

8.7 Ranbaxy

8.7.1 Ranbaxy Company Details

8.7.2 Company Description and Business Overview

8.7.3 Production and Revenue of Ketorolac

8.7.4 Ketorolac Product Introduction

8.7.5 Ranbaxy Recent Development

8.8 Adley Formulation

8.8.1 Adley Formulation Company Details

8.8.2 Company Description and Business Overview

8.8.3 Production and Revenue of Ketorolac

8.8.4 Ketorolac Product Introduction

8.8.5 Adley Formulation Recent Development

8.9 Neon Laboratories

8.9.1 Neon Laboratories Company Details

8.9.2 Company Description and Business Overview

8.9.3 Production and Revenue of Ketorolac

8.9.4 Ketorolac Product Introduction

8.9.5 Neon Laboratories Recent Development

8.10 Sun Pharmaceutical Industries

8.10.1 Sun Pharmaceutical Industries Company Details

8.10.2 Company Description and Business Overview

8.10.3 Production and Revenue of Ketorolac

8.10.4 Ketorolac Product Introduction

8.10.5 Sun Pharmaceutical Industries Recent Development

8.11 Cipla

8.12 Dallas Pharmaceuticals

8.13 Nicholas Piramal India

8.14 AHPL

9 Market Forecast

9.1 Global Market Size Forecast

9.1.1 Global Ketorolac Capacity, Production Forecast 2020-2026

9.1.2 Global Ketorolac Production Value Forecast 2020-2026

9.2 Market Forecast by Regions

9.2.1 Global Ketorolac Production and Value Forecast by Regions 2020-2026

9.2.2 Global Ketorolac Consumption Forecast by Regions 2020-2026

9.3 United States

9.3.1 Production and Value Forecast in United States

9.3.2 Consumption Forecast in United States

9.4 European Union

9.4.1 Production and Value Forecast in European Union

9.4.2 Consumption Forecast in European Union

9.5 China

9.5.1 Production and Value Forecast in China

9.5.2 Consumption Forecast in China

9.6 Rest of World

9.6.1 Japan

9.6.2 Korea

9.6.3 India

9.6.4 Southeast Asia

9.7 Forecast by Type

9.7.1 Global Ketorolac Production Forecast by Type

9.7.2 Global Ketorolac Production Value Forecast by Type

9.8 Consumption Forecast by Application

10 Value Chain and Sales Channels Analysis

10.1 Value Chain Analysis

10.2 Sales Channels Analysis

10.2.1 Ketorolac Sales Channels

10.2.2 Ketorolac Distributors

10.3 Ketorolac Customers

11 Opportunities & Challenges, Threat and Affecting Factors

11.1 Market Opportunities

11.2 Market Challenges

11.3 Porter's Five Forces Analysis

12 Key Findings

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables and Figures

Figure Ketorolac Product Picture

Table Ketorolac Key Market Segments

Table Major Manufacturers Ketorolac Covered in This Report

Table Global Ke

Please fill the form below, to recieve the report sample


+1